# Sorrento Therapeutics

Sorrento Therapeutics is a Publicly Traded Biopharmaceutical based in San Diego, United States.

## Overview

- **Organization type:** Publicly Traded Biopharmaceutical
- **Headquarters:** San Diego, United States
- **Region:** North America
- **Address:** 9380 Judicial Drive, San Diego, CA 92121, United States
- **Assets under management:** Undisclosed
- **Website:** sorrentotherapeutics.com
- **LinkedIn:** https://www.linkedin.com/company/sorrento-therapeutics-inc./?lipi=urn%3Ali%3Apage%3Ad_flagship3_search_srp_companies%3B9xUGe0bdTmmrAfZzBM2NzA%3D%3D

## Regulatory record

- **Reports private funds:** No

## About

Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19

## Sectors

- Biotechnology
- Pharmaceutical
- Oncology
- Pain Management
- COVID-19

## Offices

- Princeton
- Nashville
- Wilton
- Los Altos
- Paris
- Singapore

## Questions

### How is Sorrento Therapeutics structured — as a single entity or with subsidiaries?

Sorrento operates multiple subsidiaries, including Scilex Pharmaceuticals (pain management), a CAR-T cell therapy unit, and a diagnostics division. These are wholly owned and integrated into the parent company's development and manufacturing pipeline.

### Does Sorrento partner with external firms for development or manufacturing?

Yes, Sorrento has formed partnerships with major pharmaceutical distributors and contract manufacturing organizations to scale production and distribution, particularly for its COVID-19 diagnostics and pain therapy candidates.

### What investment stages does Sorrento Therapeutics target?

Sorrento is a development-stage biopharmaceutical company, not a family office or asset manager. Its capital deployment focuses on internal R&D, clinical trials, and manufacturing infrastructure, not external portfolio investing.

## Related profiles

- [CM Life Sciences III](https://altss.com/profile/cm-life-sciences-iii)
- [30 North Group](https://altss.com/profile/30-north-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/sorrento-therapeutics

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology